CXL Buzz Reinforces Astera's Long-Term Opportunity, But Fails to Address Near-Term Risks

What happened

A new article from 24/7 Wall Street highlights the surge in DRAM prices and Micron's expectation of tightness through 2028, suggesting CXL as the next investment play. Astera Labs, with its Leo CXL memory controllers and Scorpio fabric switches, is positioned to benefit if CXL adoption accelerates in AI and cloud infrastructure. However, the company's own filings show CXL remains in early-adoption phase, with management framing UALink/CXL as a risk factor and no disclosed production revenue from CXL products. Moreover, the stock trades at 166.7x earnings and 275.1x EV/EBITDA, with extreme customer concentration and gross margin pressure from the Scorpio ramp. Thus, while the article aligns with Astera's long-term narrative, it provides no new information to mitigate the current overvaluation and execution risks.

Implication

The article's focus on CXL as the next play could attract retail interest, but it does not change the fundamentals. Astera's CXL products are still in early stages; without production revenue, the market's excitement may be premature. The company's high valuation already embeds significant growth expectations, including successful CXL ramp, leaving little room for error. Near-term risks, such as gross margin compression from Scorpio's hardware-heavy mix and customer concentration, remain unresolved. Therefore, investors should wait for evidence of CXL revenue contribution and broadening customer base before considering entry at current levels.

Thesis delta

No material shift. The article reiterates the CXL opportunity that Astera is pursuing, but it does not provide new evidence of accelerated adoption or company-specific traction. The investment thesis remains a WAIT, with the stock overpriced relative to the proof points required.